BALTIMORE, Feb. 12, 2025 /PRNewswire/ — Today, Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, which provides additional clinical validation of Esopredict®, the only commercially available test that uses DNA…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.